Alumis Inc Stock Performance
| ALMS Stock | 24.52 1.76 6.70% |
Alumis holds a performance score of 19 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.97, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alumis will likely underperform. Use Alumis value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on Alumis.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Alumis Inc are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Alumis unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (6.70) | Five Day Return 5.15 | Year To Date Return 173.66 | Ten Year Return 84.36 | All Time Return 84.36 |
1 | Alumis to Participate in Upcoming November Investor Conferences | 11/04/2025 |
2 | Acquisition by Akkaraju Srinivas of 102652 shares of Alumis at 6.05 subject to Rule 16b-3 | 11/18/2025 |
3 | Director Makes a Bold Move with Major Stock Purchase in Alumis Inc. - TipRanks | 11/24/2025 |
4 | Acquisition by Akkaraju Srinivas of 48537 shares of Alumis at 7.64 subject to Rule 16b-3 | 11/26/2025 |
5 | Acquisition by Akkaraju Srinivas of 38702 shares of Alumis at 7.64 subject to Rule 16b-3 | 11/28/2025 |
6 | Acquisition by Akkaraju Srinivas of 86350 shares of Alumis at 7.46 subject to Rule 16b-3 | 12/01/2025 |
7 | Acquisition by Akkaraju Srinivas of 100000 shares of Alumis at 7.75 subject to Rule 16b-3 | 12/03/2025 |
8 | Alumis versus Its Peers Critical Contrast | 12/16/2025 |
9 | Alumis Skin Drug Shows Clear Benefits In Late Trials, Stock Soars | 01/06/2026 |
10 | Assessing Alumis Valuation After Positive Envudeucitinib Phase 3 Trial Success | 01/07/2026 |
11 | Alumis Is Up 83.6 percent After Phase 3 Psoriasis Win And NDA Plan - Has The Bull Case Changed | 01/08/2026 |
12 | Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares | 01/09/2026 |
13 | Latham Watkins Advises on Alumis Upsized US345 Million Public Offering of Common Stock - Legal Desire Media and Insights | 01/13/2026 |
14 | HC Wainwright Co. Hikes Alumis Inc. s Price Target To 40 From 20, Reiterates Buy Rating | 01/15/2026 |
15 | Chardan Capital Begins Coverage on Alumis | 01/22/2026 |
| Begin Period Cash Flow | 47.1 M | |
| Total Cashflows From Investing Activities | -113.8 M |
Alumis Relative Risk vs. Return Landscape
If you would invest 481.00 in Alumis Inc on October 26, 2025 and sell it today you would earn a total of 1,971 from holding Alumis Inc or generate 409.77% return on investment over 90 days. Alumis Inc is currently generating 3.3202% in daily expected returns and assumes 13.4891% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Alumis, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Alumis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alumis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alumis Inc, and traders can use it to determine the average amount a Alumis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Alumis is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alumis by adding it to a well-diversified portfolio.
Alumis Fundamentals Growth
Alumis Stock prices reflect investors' perceptions of the future prospects and financial health of Alumis, and Alumis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alumis Stock performance.
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.61 | ||||
| Operating Margin | (53.72) % | ||||
| Current Valuation | 2.94 B | ||||
| Shares Outstanding | 117.51 M | ||||
| Price To Book | 8.52 X | ||||
| Price To Sales | 138.21 X | ||||
| Gross Profit | 22.12 M | ||||
| EBITDA | (297.6 M) | ||||
| Net Income | (294.23 M) | ||||
| Total Debt | 30.72 M | ||||
| Book Value Per Share | 3.69 X | ||||
| Cash Flow From Operations | (255.08 M) | ||||
| Earnings Per Share | (2.15) X | ||||
| Market Capitalization | 3.06 B | ||||
| Total Asset | 340.99 M | ||||
| Retained Earnings | (658.55 M) | ||||
| Working Capital | 255.28 M | ||||
About Alumis Performance
Assessing Alumis' fundamental ratios provides investors with valuable insights into Alumis' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Alumis is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.78) | (0.82) | |
| Return On Capital Employed | (0.93) | (0.98) | |
| Return On Assets | (0.78) | (0.82) | |
| Return On Equity | (1.30) | (1.24) |
Things to note about Alumis Inc performance evaluation
Checking the ongoing alerts about Alumis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alumis Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alumis Inc is way too risky over 90 days horizon | |
| Alumis Inc appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (294.23 M) with profit before overhead, payroll, taxes, and interest of 22.12 M. | |
| Alumis generates negative cash flow from operations | |
| About 69.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum 18 Companies Lead the Charge in Pioneering New Treatments DelveInsight |
- Analyzing Alumis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alumis' stock is overvalued or undervalued compared to its peers.
- Examining Alumis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alumis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alumis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alumis' stock. These opinions can provide insight into Alumis' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Alumis Stock Analysis
When running Alumis' price analysis, check to measure Alumis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alumis is operating at the current time. Most of Alumis' value examination focuses on studying past and present price action to predict the probability of Alumis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alumis' price. Additionally, you may evaluate how the addition of Alumis to your portfolios can decrease your overall portfolio volatility.